Welcome to our dedicated page for Kewaunee Scienti news (Ticker: KEQU), a resource for investors and traders seeking the latest updates and insights on Kewaunee Scienti stock.
Overview
Kewaunee Scientific Corporation (KEQU) is a global designer, manufacturer, and installer of innovative laboratory and technical furniture products. Catering to research, healthcare, education, government, and industrial markets, the company provides sophisticated solutions that create safe, functional, and adaptable work environments. By emphasizing high-quality design and precise engineering, Kewaunee Scientific stands out in the competitive landscape of laboratory furnishings and technical workspace solutions.
Core Business Segments
The Company operates through two primary segments. The Domestic segment focuses on the comprehensive design, manufacture, and installation of furniture products, including laboratory cabinetry, fume hoods, moveable workstations, and advanced modular systems. On the international front, the Company offers facility design, engineering, and project management services from the planning stage through installation and commissioning, ensuring that its innovative solutions meet the diverse needs of global markets.
Product Portfolio and Capabilities
Kewaunee Scientific delivers a broad range of products categorized under laboratory, technical, and laminate furniture. The laboratory product range involves both steel and wood cabinetry, environmentally friendly casework, and specialized systems such as biological safety cabinets and epoxy resin work surfaces. Technical furniture offerings include column systems, slotted-post assemblies, pedestal systems, and stand-alone benches, designed for robust performance in demanding research and industrial environments. In addition, the laminate furniture division provides flexible casework and system solutions ideal for educational and healthcare settings.
Global Footprint and Manufacturing Excellence
With corporate headquarters in Statesville, North Carolina, Kewaunee Scientific operates multiple manufacturing facilities, predominantly in Statesville and Bangalore, India. This global network not only serves domestic clients but also addresses the evolving needs of international markets. The widespread presence of sales offices further enhances the company’s ability to consult with customers and deliver tailored design solutions efficiently.
Market Position and Competitive Landscape
In an industry where precision and adaptability are vital, Kewaunee Scientific has positioned itself as a respected alternative in the laboratory and technical furniture space. Its comprehensive product range, spanning from steel and wood laboratory cabinetry to innovative modular laboratory systems, underpins its ability to serve a diverse customer base. The company’s integrated approach—combining design, engineering, manufacturing, and installation—provides clear differentiation from competitors. Additionally, strategic moves such as targeted acquisitions have enhanced its product offerings and geographic reach, reinforcing its market significance without relying on transient performance metrics.
Business Model and Operational Expertise
Revenue is generated through direct product sales, complete project implementations, and specialized installation services. The company’s business model is characterized by a focus on durable, cutting-edge solutions that are backed by thoughtful engineering and state-of-the-art manufacturing processes. This model supports consistent product quality and operational excellence, contributing to superior client satisfaction and repeat business from a loyal customer base across research, commercial, and technical sectors.
Innovation, Expansion, and Strategic Initiatives
One notable element of Kewaunee Scientific’s strategic evolution is its commitment to expanding its technological and product capabilities. The company has made measured acquisitions, incorporating complementary product lines that extend its influence within critical sectors such as life sciences, healthcare, and industrial research. These initiatives have consolidated its portfolio, allowing integrated offerings that meet the comprehensive needs of the laboratory environment. As a result, the company continues to demonstrate that its innovative solutions are a result of deep industry knowledge and a consistent focus on operational precision.
Expertise and Industry Relevance
Drawing upon decades of industry experience, Kewaunee Scientific leverages its expertise to drive customer-specific design and execution. Every product and service is developed with an understanding of rigorous laboratory requirements, ensuring precision, durability, and safety. The use of technical terminology and an emphasis on tailored solutions reflects both the depth of the company’s experience and its commitment to quality. By consistently delivering functional and reliable products, Kewaunee Scientific has fostered strong trust among customers and stakeholders in the research and technical sectors.
Conclusion
Summarizing its multifaceted operations, Kewaunee Scientific Corporation exemplifies a comprehensive approach to laboratory and technical workspace design. With a focus on advanced product development, strategic global operations, and a steadfast commitment to quality, the company has built a reputation for excellence in creating environments where discovery and innovation thrive. Its detailed integration of design, manufacturing, and installation illustrates a robust business model geared toward long-term sustainability in a dynamic market landscape.
Kewaunee Scientific (NASDAQ: KEQU) has announced an amendment to its share repurchase program on March 12, 2025. The Board of Directors has authorized the repurchase of an additional 100,000 shares of common stock, adding to the 11,176 shares still authorized under the existing program that began September 1, 2023.
The company temporarily paused repurchases to focus on the acquisition of Nu Aire, Inc., which closed on November 1, 2024, after repurchasing the maximum allowable shares under their prior credit agreement between October 2023 and April 2024. Share repurchases resumed on February 28, 2025.
The program's timing and amount will be determined by management based on capital needs, stock price, and market conditions. The company maintains flexibility to suspend or discontinue the program at any time.
Kewaunee Scientific (NASDAQ: KEQU) reported its Q3 FY2025 results with sales of $67.17 million, up 43.6% year-over-year. However, pre-tax earnings decreased 63.7% to $1.28 million, with diluted EPS falling to $0.45 from $0.85.
The quarter included costs related to the Nu Aire acquisition, completed on November 1, 2024. Adjusting for acquisition and integration costs of $2.51 million, adjusted pre-tax earnings were $3.79 million, up 7.8% YoY, with adjusted EPS of $1.09.
Key metrics include:
- Order backlog: $221.6 million (up from $152.3 million YoY)
- Domestic sales: $51.98 million (+63.6% YoY)
- International sales: $15.19 million (+1.2% YoY)
- Cash position: $12.34 million
- Debt-to-equity ratio: 1.29-to-1
The company's Domestic segment showed strong performance, while the International segment faced challenges due to customer site delays. Management remains focused on operational excellence and strategic growth initiatives.
Kewaunee Scientific (NASDAQ: KEQU) has announced it will release its third quarter fiscal year 2025 financial results on March 12, 2025 after market close. The results will be available on the company's website.
Founded in 1906, Kewaunee Scientific is a global leader in laboratory, healthcare, and technical furniture products manufacturing. The company operates manufacturing facilities in Statesville, North Carolina, and Bangalore, India. Through its recently acquired subsidiary Nu Aire, founded in 1971, the company has expanded its portfolio to include biological safety cabinets, CO2 incubators, and ultralow freezers. Nu Aire's facilities are located in Plymouth and Long Lake, Minnesota.
Kewaunee Scientific (NASDAQ: KEQU) reported Q2 FY2025 results with sales of $47.76M, down 5.3% YoY. Pre-tax earnings decreased 18.9% to $3.93M, while net earnings increased to $3.01M from $2.73M. The company's order backlog reached a historic high of $184.4M.
Domestic segment sales grew 6.5% to $36.41M, while International segment sales declined 30.1% to $11.36M due to construction delays in India. The company maintained strong liquidity with $29.66M cash on hand and reduced its debt-to-equity ratio to 0.59-to-1.
On November 1, 2024, Kewaunee completed the acquisition of Nu Aire, Inc., a leading manufacturer of biological safety cabinets and airflow products, incurring $2.3M in acquisition-related expenses during the quarter.
Kewaunee Scientific (NASDAQ: KEQU) announced it will release its second quarter fiscal year 2025 financial results on Wednesday, December 11, 2024 after market close. The results will be available on the company's website. Kewaunee Scientific, founded in 1906, is a global leader in laboratory, healthcare, and technical furniture products manufacturing, with headquarters in Statesville, North Carolina and manufacturing facilities in the US and India.
Kewaunee Scientific (NASDAQ: KEQU) has completed the acquisition of Nu Aire, a Minneapolis-based manufacturer of laboratory equipment, for $55 million. Nu Aire specializes in biological safety cabinets, airflow products, CO2 incubators, and related equipment serving life sciences, healthcare, and education sectors. The acquisition expands Kewaunee's product portfolio and market reach through Nu Aire's established distribution network. Bill Peters will continue as Nu Aire's President and join Kewaunee's corporate management team. The combined organization aims to enhance product offerings and leverage operational synergies for improved performance and sustainable growth.
Kewaunee Scientific (NASDAQ: KEQU) reported its Q1 FY2025 results. Key highlights include:
- Sales decreased 2.9% to $48,393,000
- Pre-tax earnings fell 28.8% to $2,430,000
- Net earnings decreased to $2,193,000
- Diluted EPS dropped to $0.74 from $0.86
- Order backlog increased to $159.4 million
- Domestic sales rose 0.3% to $35,523,000
- International sales declined 10.7% to $12,870,000
The company maintained a strong financial position with $25,186,000 in cash and a debt-to-equity ratio of 0.68-to-1. Despite challenges in the international segment due to project delays in India, the domestic segment showed improved performance. The company's CEO expressed confidence in another strong year based on the robust backlog and high quoting activity.
Kewaunee Scientific (NASDAQ: KEQU), a global leader in laboratory, healthcare, and technical furniture products, announces its participation in the 2024 Arablab Live tradeshow in Dubai from September 24-26. The event will host industry professionals from over 120 countries, showcasing innovations in life sciences, clean energy, industrial, and chemical sectors.
Kewaunee's executive and sales teams will be present at Hall 3, Stand 708 of the Dubai World Trade Centre, offering product demonstrations and networking opportunities. The company aims to connect with international partners, exchange knowledge, and highlight its innovative solutions for laboratory spaces worldwide.
Kewaunee Scientific (NASDAQ: KEQU) has announced plans to release its first quarter fiscal year 2025 financial results on Wednesday, September 11, 2024, after the close of trading. The information will be available on the company's website following the release.
Kewaunee Scientific, founded in 1906, is a global leader in designing, manufacturing, and installing laboratory, healthcare, and technical furniture products. The company's product range includes steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Headquartered in Statesville, North Carolina, Kewaunee Scientific has sales offices in the United States, India, Saudi Arabia, and Singapore. It operates three manufacturing facilities in Statesville and one in Bangalore, India, serving domestic and international markets.
Kewaunee Scientific announced its fiscal year and fourth quarter results for the period ending April 30, 2024. Fourth quarter sales increased by 5% to $56.7 million, with adjusted net earnings rising to $4.6 million from $1 million year-over-year. Adjusted diluted earnings per share for the quarter were $1.55, up from $0.34. For the fiscal year, sales dropped by 7.2% to $203.8 million, while adjusted net earnings surged to $12.3 million from $738,000. Adjusted EBITDA for the fiscal year was $20.7 million, up from $7.5 million. The order backlog rose to $155.6 million. The company also noted two significant non-recurring transactions: the annuitization of its pension obligations and the reversal of a valuation allowance, impacting earnings and EBITDA.
FAQ
What is the current stock price of Kewaunee Scienti (KEQU)?
What is the market cap of Kewaunee Scienti (KEQU)?
What is the core business of Kewaunee Scientific Corporation?
What types of products does the company offer?
How does Kewaunee Scientific generate revenue?
What industries are served by Kewaunee Scientific?
How is the company structured globally?
What distinguishes Kewaunee Scientific in the competitive market?
Has the company undertaken any significant strategic initiatives?
How does Kewaunee Scientific maintain product quality and innovation?
